A detailed history of Mc Collum Christoferson Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mc Collum Christoferson Group LLC holds 516 shares of LLY stock, worth $396,164. This represents 0.14% of its overall portfolio holdings.

Number of Shares
516
Previous 516 -0.0%
Holding current value
$396,164
Previous $467,000 2.14%
% of portfolio
0.14%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $14,497 - $18,180
20 Added 4.03%
516 $467,000
Q1 2024

Apr 26, 2024

BUY
$592.2 - $792.28 $27,241 - $36,444
46 Added 10.22%
496 $385,000
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $157,833 - $211,041
450 New
450 $211,000
Q4 2020

Jan 22, 2021

SELL
$130.46 - $172.63 $228,305 - $302,102
-1,750 Closed
0 $0
Q3 2020

Oct 22, 2020

BUY
$146.22 - $169.13 $255,885 - $295,977
1,750 New
1,750 $259,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mc Collum Christoferson Group LLC Portfolio

Follow Mc Collum Christoferson Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Collum Christoferson Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Collum Christoferson Group LLC with notifications on news.